Document is current
Any future updates will be listed below
-
Authors
Yang, Li
Zhao, Ling
Chen, XingQu
Yi, ChuanYun
Wang, XiaoQin
Yu, DeShui
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2400087524 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Respiratory and circulatory safety of ciprofol combined with remifentanil during fiberoptic bronchoscopy in Chinese patients with tuberculosis: a randomized, double-blind, controlled trial
https://doi.org/10.1186/s40001-026-04477-8
-
Funding
Funding for this research was provided by:
Special Scientific Research Project of Sichuan Medical Association on Sedation and Analgesia (2024RF14)
- License Information
-
More Information
Article History
Received: 26 September 2025
Accepted: 14 April 2026
First Online: 22 April 2026
Declarations
:
: This research was approved by the Ethics Committee of The Second People’s Hospital of Yibin City (Approval No. 2024-130-01), and was registered in the Chinese Clinical Trial Registry (Reregistration No: ChiCTR2400087524). Informed consent is signed by all participants. Our study followed the Criteria for the Quality Control of Clinical Trial of drugs.
: Not applicable.
: The authors declare no competing interests.
